View in EDS

Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients.

Saved in:
Bibliographic Details
Title: Endocrine therapy or chemotherapy as first-line therapy in hormone receptor–positive HER2-negative metastatic breast cancer patients.
Authors: Jacquet, E.1, Lardy-Cléaud, A.2, Pistilli, B.3, Franck, S.4, Cottu, P.4, Delaloge, S.3, Debled, M.5, Vanlemmens, L.6, Leheurteur, M.7, Guizard, A.V.8, Laborde, L.9, Uwer, L.10, Jacot, W.11, Berchery, D.12, Desmoulins, I.13, Ferrero, J.M.14, Perrocheau, G.15, Courtinard, C.16, Brain, E.4, Chabaud, S.2
Source: European Journal of Cancer. May2018, Vol. 95, p93-101. 9p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2018.03.013